STAND. COM. REP. NO. 1079-18

Honolulu, Hawaii

, 2018

RE: H.B. No. 1893

H.D. 1

Honorable Scott K. Saiki

Speaker, House of Representatives

Twenty-Ninth State Legislature

Regular Session of 2018

State of Hawaii

Sir:

Your Committee on Judiciary, to which was referred H.B. No. 1893, H.D. 1, entitled:

"A BILL FOR AN ACT RELATING TO HEALTH,"

begs leave to report as follows:

The purpose of this measure is to specify that certain activities relating to prescription drugs containing cannabidiol, including prescribing, dispensing, possession, and transportation, and the use of prescription drugs containing cannabidiol, shall become lawful upon the approval by the federal Food and Drug Administration of one or more prescription drugs containing cannabidiol.

The Epilepsy Foundation, Dravet Syndrome Foundation, Epilepsy Foundation of Hawaii, Lennox-Gastaut Syndrome Foundation, Tuberous Sclerosis Alliance, Oahu County Committee on Legislative Priorities of the Democratic Party of Hawaii, and an individual supported this measure. The Department of the Attorney General opposed this measure. The Department of Public Safety, Hawaii Substance Abuse Coalition, and Greenwich Biosciences provided comments.

As affirmed by the record of votes of the members of your Committee on Judiciary that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 1893, H.D. 1, and recommends that it pass Third Reading.

Respectfully submitted on behalf of the members of the Committee on Judiciary,

____________________________

SCOTT Y. NISHIMOTO, Chair